Press release
Pancreatic and Bile Duct Cancer Drug Market to 2027, Future Outlook, COVID-19 Impact Analysis, Forecast 2021-2027
The global pancreatic and bile duct cancer drug market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Some major factors that are anticipated to drive the market growth include the rising prevalence of pancreatic cancer and cholangiocarcinoma. Pancreatic and bile duct cancer drugs are of different types. Some drugs treat cancer, whereas, others support relieving symptoms such as sickness and pain. 5-fluorouracil, gemcitabine, cisplatin, capecitabine, oxaliplatin are the commonly used drugs for bile duct cancer. Abraxane, Afinitor, erlotinib hydrochloride, everolimus, and 5-FU are among the approved drugs for pancreatic cancer.A full report of Pancreatic and Bile Duct Cancer Drug Market is available at: https://www.omrglobal.com/industry-reports/pancreatic-and-bile-duct-cancer-drug-market
The rise in pancreatic cancer patients across the globe due to factors such as age, smoking, diabetes and family history, also drive demand for pancreatic and bile duct cancer drugs. The global pancreatic and bile duct cancer drug market analysis includes some of the key market players such as 3-V Biosciences Inc., 4P-Pharma SAS, 4SC AG, AB Science SA, AbbVie Inc., AbGenomics International Inc., and Ability Pharmaceuticals SL, among others. To maintain a strong position in the market, the market players are adopting various strategic moves, such as product launches, partnerships, collaborations, and mergers and acquisitions. Further, in December 2021, scientists at Washington University School of Medicine in St. Louis have discovered a drug combination that renders pancreatic cancer cells more vulnerable to chemotherapy. FOLFIRINOX is the first-line treatment for pancreatic cancer, however, only around one out of every three patients will see their tumor shrink. The researchers plan to continue exploring ATI-450 for pancreatic cancer, particularly if this medicine in combination with other investigational treatments, such as immunotherapies, can be effective.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/pancreatic-and-bile-duct-cancer-drug-market
Market Coverage
• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered
• Regions Covered- Globally
• Competitive Landscape: 3-V Biosciences Inc., 4P-Pharma SAS, 4SC AG, AB Science SA, AbbVie Inc., AbGenomics International Inc., and Ability Pharmaceuticals SL, among others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Pancreatic and Bile Duct Cancer Drug Market Report Segmentation
By Product Type
• Vascular Endothelial Growth Factor Receptors
• Programmed Cell Death Protein 1
• Others
By Application
• Pancreatic Cancer
• Cholangiocarcinoma
Pancreatic and Bile Duct Cancer Drug Market– Segment by Region
North America
• United States
• Canada
Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World
• Middle East & Africa
• Latin America
Company Profiles
• 3-V Biosciences Inc.
• 4P-Pharma SAS
• 4SC AG
• AB Science SA
• AbbVie Inc.
• AbGenomics International Inc.
• Ability Pharmaceuticals SL
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pancreatic and Bile Duct Cancer Drug Market to 2027, Future Outlook, COVID-19 Impact Analysis, Forecast 2021-2027 here
News-ID: 2526007 • Views: …
More Releases from Orion Market Research
Moringa Products Market Increasing Demand, Growth Analysis and Future Outlook by …
The global moringa products market is anticipated to grow at a significant CAGR of 4.2% during the forecast period. The market is primarily driven by the rising consumption of fast food products among people has increased the incidences of obesity among people. Furthermore, the growing production of has also been subsequently increased which contribute to the growth of the moringa products market. According to World Health Organization (WHO), 39 million children…
Moringa Ingredients Market is Likely to Increase at a Significantly High CAGR du …
Moringa ingredients market is projected to grow at a significant CAGR during the forecast period. The moringa ingredients are available from various sources including leaves, seeds, oil, and fruits. The study of the global moringa ingredients market reports covers the analysis of various applications such as food & beverage, cosmetic & personal care, pharmaceutical, and others. The food and beverage segment of the market is projected to contribute significantly during…
Men's Wear Market is Size, Trends, Latest Insights, Analysis and Forecast 2024-2 …
The global men's wear market is anticipated to grow at a CAGR of 5.6% during the forecast period. The major factor driving the growth of the men's wear market includes a rapidly changing lifestyle coupled with the increasing purchasing power of the middle-class population. The increasing millennial population across the globe that is opting for luxury products is also influencing the growth of the men's wear market.
Moreover, internet penetration is…
Men's Skincare Products Market Size, Share, Trends, Demand, Segments, Leading Co …
The global men's skincare products market is anticipated to grow at a considerable CAGR of 6.5% during the forecast period. The growing awareness among males associated with personal grooming is one of the prime factors affecting and driving the market for men's skincare products. In recent times, there has been observed a rise in spending on male toiletries along with an increase in need and requirements for more male-specific care products. Additionally,…
More Releases for Pancreatic
Pancreatic Cancer Therapy Market: Rise in Number of Patients Suffering with Panc …
Pancreatic cancer is one of the aggressive cancers that originate in the tissues of the pancreas and rapidly spreads to the nearby organs. Pancreatic cancer is the 12th most commonly occurring cancer in the world. According to the American Cancer Society, ~55,440 patients in the US are expected to be diagnosed with pancreatic cancer in 2018. Moreover, the ACS also reports that pancreatic cancer is the third leading cause of…
Pancreatic Cancer Treatment
Pancreatic Cancer Treatment Market describes its growth, size, share, Forecast and trends to 2025
Pancreatic Cancer Treatment Market Production and Demand Analysis 2019 to 2025
Pancreatic Cancer Treatment Market 2019 Manufacturing Analysis and Development Forecast 2025
Pancreatic Cancer Treatment Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025
Pancreatic Market to Insight By 2025: Top Key Vendors
Pancreatic cancer arises when cells in the pancreas, a glandular organ behind the stomach, begin to…
Exocrine Pancreatic Insufficiency (EPI) Therapeutics- Pipeline Analysis
Exocrine pancreatic insufficiency (EPI) is the inability of pancreas to produce enough enzymes for the proper breakdown and absorption of nutrients. The common causes of EPI are damage to pancreas, inflammation of pancreas, pancreatic surgery, and inherited disorders like Crohn’s disease and celiac disease.
Download the sample report at: https://www.pharmaproff.com/request-sample/1024
Some symptoms observed during EPI are pain or tenderness in belly, bad-smelling bowel movements, gas, diarrhea and feeling of fullness. EPI…
Pancreatic Cancer Pipeline Review H1 2019
Pancreatic Cancer - Pipeline Review, H1 2017
Summary
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Pancreatic Cancer - Pipeline Review, H1 2017, provides an overview of the Pancreatic Cancer (Oncology) pipeline landscape.
Pancreatic cancer is a disease in which malignant (cancer) cells are found in the tissues of the pancreas. This is also called exocrine cancer. Signs and symptoms include upper abdominal pain that may radiate to back, yellowing of skin and…
Pancreatic Cancer Drug Pipeline Analysis
“Pancreatic Cancer Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles being developed for the treatment of Pancreatic Cancer. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. Insight for each…
Exocrine Pancreatic Insufficiency Market 2013
Transparency Market Research has published a new market report titled, “Exocrine Pancreatic Insufficiency Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2013 – 2023.” According to the report, the exocrine pancreatic insufficiency market is anticipated to expand at a CAGR of 8.3% from 2015 to 2023 to reach US$2.85 Bn by 2023.
Browse the full Exocrine Pancreatic Insufficiency Market – (Therapeutic – Pancreatic Enzyme Replacement Therapy (Creon, Zenpep,…
